Objective: To report our management of bilateral adrenalectomy with autologous adrenal gland transplantation for persistent Cushing’s disease, and to discuss the feasibility of autologous adrenal transplantation for the treatment of refractory Cushing’s disease. Material and Methods: A retrospective analysis was performed in 4 patients (3 females, aged 14–36 years) who underwent autologous adrenal transplantation for persistent Cushing’s disease after endonasal transsphenoidal resection of a pituitary tumor. The procedure was performed by implanting a vascularized adrenal graft into the left iliac fossa with direct and indirect anastomoses. Postoperative follow-up was performed in 1, 1.5, 8, and 10 years, and an over 8-year long-term follow-up was reached in 2 out of the 4 cases. Hormone replacement dosage was guided by clinical symptoms and endocrine results including serum cortisol (F), 24 h urine-free cortisol, and adrenocorticotrophic hormone levels. Results: All 4 patients with symptomatic Cushing’s disease experienced resolution of symptoms after autotransplantation without Nelson Syndrome. Functional autografts were confirmed through clinical evaluation and endocrine results. One year after transplantation, adrenal function and hormone replacement dosage remained stable without adrenal hyperplasia. After long-term follow-up, dosages of hormone replacement were reduced in all patients. Conclusions: In this series of 4 patients, we demonstrate the long-term efficacy of bilateral adrenalectomy with autologous adrenal transplantation and propose this procedure as a viable treatment option for refractory Cushing’s disease.

Keywords:
Adrenalectomy, Autologous adrenal gland transplantation , Cortisol, Cushing’s disease, Nelson syndrome
1.
Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, et al. Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement.
J Clin Endocrinol Metab
. 2008 Jul;93(7):2454–62.
2.
Hammer GD, Tyrrell JB, Lamborn KR, Applebury CB, Hannegan ET, Bell S, et al. Transsphenoidal microsurgery for Cushing’s disease: initial outcome and long-term results.
J Clin Endocrinol Metab
. 2004 Dec;89(12):6348–57.
3.
Espinosa-de-Los-Monteros AL, Sosa-Eroza E, Espinosa E, Mendoza V, Arreola R, Mercado M. Long-term outcome of the different treatment alternatives for recurrent and persistent Cushing disease.
Endocr Pract
. 2017 Jul;23(7):759–67.
4.
Assié G, Bahurel H, Coste J, Silvera S, Kujas M, Dugué MA, et al. Corticotroph tumor progression after adrenalectomy in Cushing’s Disease: A reappraisal of Nelson’s Syndrome.
J Clin Endocrinol Metab
. 2007 Jan;92(1):172–9.
5.
Liu JK, Fleseriu M, Delashaw JB Jr, Ciric IS, Couldwell WT. Treatment options for Cushing disease after unsuccessful transsphenoidal surgery.
Neurosurg Focus
. 2007;23(3):E8.
6.
Pecori Giraldi F, Andrioli M, De Marinis L, Bianchi A, Giampietro A, De Martin M, et al. Significant GH deficiency after long-term cure by surgery in adult patients with Cushing’s disease.
Eur J Endocrinol
. 2007 Feb;156(2):233–9.
7.
Ismailov SI, Rashitov MM. Adrenal autotransplantation in clinic.
Transplantation
. 2004;78(2):431–2.
8.
Miyauchi A, Kihara M, Matsusaka K, Nishitani A, Nishiyama Y. Successful autotransplantation of an adrenal gland using a new method of omental wrapping: report of a case.
Surg Today
. 1999;29(9):960–2.
9.
Grodstein E, Hardy MA, Goldstein MJ. A case of human intramuscular adrenal gland transplantation as a cure for chronic adrenal insufficiency.
Am J Transplant
. 2010 Feb;10(2):431–3.
10.
Xu YM, Chen ZD, Qiao Y, Jin NT. The value of adrenal autotransplantation with attached blood vessels for the treatment of Cushing’s disease: a preliminary report.
J Urol
. 1992 May;147(5):1209–11.
11.
Wang PY. Autologous adrenal transplantation.
Chin J Urol.
2003;9:642–4.
12.
Shi YF.
Union Medical College Endocrine and Metabolism
. Beijing: Scientific Publishing; 1999. pp. 1144–5.
13.
Munir A, Newell-Price J. Nelson’s Syndrome.
Arq Bras Endocrinol Metabol
. 2007 Nov;51(8):1392–6.
14.
Vance ML. Cushing’s disease: radiation therapy.
Pituitary
. 2009;12(1):11–4.
15.
Nagesser SK, van Seters AP, Kievit J, Hermans J, Krans HM, van de Velde CJ. Long-term results of total adrenalectomy for Cushing’s disease.
World J Surg
. 2000 Jan;24(1):108–13.
16.
Demeter JG, De Jong SA, Brooks MH, Lawrence AM, Paloyan E. Long-term results of adrenal autotransplantation in Cushing’s disease.
Surgery
. 1990 Dec;108(6):1117–22.
17.
Aghi MK. Management of recurrent and refractory Cushing disease.
Nat Clin Pract Endocrinol Metab
. 2008 Oct;4(10):560–8.
18.
Cui X, Yang L, Li J, Bu S, Wei Q, An Z, et al. Perioperative endocrine therapy for patients with Cushing’s syndrome undergoing retroperitoneal laparoscopic adrenalectomy.
Int J Endocrinol
. 2012;2012:983965.
19.
Tang K, Wang L, Yang Z, Sui Y, Li L, Huang Y, et al. Comparison of hydrocortisone and prednisone in the glucocorticoid replacement therapy post-adrenalectomy of Cushing’s Syndrome.
Oncotarget
. 2017 Aug;8(62):106113–20.
20.
Gil-Cárdenas A, Herrera MF, Díaz-Polanco A, Rios JM, Pantoja JP. Nelson’s syndrome after bilateral adrenalectomy for Cushing’s disease.
Surgery
. 2007 Feb;141(2):147–51.
21.
Jenkins PJ, Trainer PJ, Plowman PN, Shand WS, Grossman AB, Wass JA, et al. The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin-dependent Cushing’s syndrome.
J Clin Endocrinol Metab
. 1995 Jan;80(1):165–71.
22.
Kelly DF. Transsphenoidal surgery for Cushing’s disease: a review of success rates, remission predictors, management of failed surgery, and Nelson’s Syndrome.
Neurosurg Focus
. 2007;23(3):E5.
23.
Patel J, Eloy JA, Liu JK. Nelson’s syndrome: a review of the clinical manifestations, pathophysiology, and treatment strategies.
Neurosurg Focus
. 2015 Feb;38(2):E14.
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.